4861 - 4870 of 8620 Results
Title
Year
- A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease2023RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
- Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults2016RESTRICTEDTitle: Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adultsJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 5Start Page: 973End Page: 978Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12974Citation Count: 13
- Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias2021OPENTitle: Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic ParaplegiasJournal Name: iSciencePublisher: Elsevier BVVol: 24Issue #: 5Start Page: 102484End Page: 102484Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2021.102484Best OA location URL: http://www.cell.com/article/S2589004221004521/pdfCitation Count: 9
- Proteomic and functional data sets on synaptic mitochondria from rats with genetic ablation of Parkin2018OPENTitle: Proteomic and functional data sets on synaptic mitochondria from rats with genetic ablation of ParkinJournal Name: Data in BriefPublisher: Elsevier BVVol: 20Issue #:Start Page: 568End Page: 572Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.dib.2018.08.053Best OA location URL: https://doi.org/10.1016/j.dib.2018.08.053Citation Count: 2
-
OPENTitle: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patientsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100042End Page: 100042Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100042Citation Count: 8
- Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)2022RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 2
- Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists2025RESTRICTEDTitle: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 124Issue #:Start Page: 130259End Page: 130259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259Citation Count: 0
- Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies2024OPENTitle: Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathiesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae163Best OA location URL: https://doi.org/10.1093/braincomms/fcae163Citation Count: 1
- The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease2024OPENTitle: The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00826-8Best OA location URL: https://doi.org/10.1038/s41531-024-00826-8Citation Count: 2
- Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model2025OPENTitle: Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat modelJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf204Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf204/63390781/fcaf204.pdfCitation Count: 0